...
首页> 外文期刊>BMC Systems Biology >Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine
【24h】

Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine

机译:通过针对小ber碱的多发性骨髓瘤细胞中种子靶向抑制的差异miRNA的综合分析和miR-21的功能研究

获取原文
           

摘要

Background Berberine is a natural alkaloid derived from a traditional Chinese herbal medicine. It is known to modulate microRNA (miRNA) levels, although the mechanism for this action is unknown. Here, we previously demonstrate that the expression of 87 miRNAs is differentially affected by berberine in multiple myeloma cells. Among 49 miRNAs that are down-regulated, nine act as oncomirs, including miR-21. Integrative analysis showed that 28 of the down-regulated miRNAs participate in tumor protein p53 (TP53) signaling and other cancer pathways. miR-21 is involved in all these pathways, and is one of the most important oncomirs to be affected by berberine in multiple myeloma cells. Results We confirmed that berberine down-regulated miRNA-21 expression and significantly up-regulated the expression of programmed cell death 4 (PDCD4), a predicted miR-21 target. Luciferase reporter assays confirmed that PDCD4 was directly regulated by miR-21. Bioinformatic analysis revealed that the miR-21 promoter can be targeted by signal transducer and activator of transcription 3 (STAT3). Down-regulation of interleukin 6 (IL6) by berberine might lead to inhibition of miR-21 transcription through STAT3 down-regulation in multiple myeloma. Furthermore, both berberine and seed-targeting anti-miR-21 oligonucleotide induced apoptosis, G2-phase cell cycle arrest and colony inhibition in multiple myeloma cell lines. Depletion of PDCD4 by short interfering RNA could rescue berberine-induced cytotoxicity in multiple myeloma cells. Conclusions Our results suggest that berberine suppresses multiple myeloma cell growth, at least in part, by down-regulating miR-21 levels possibly through IL6/STAT3. This led to increased PDCD4 expression, which is likely to result in suppression of the p53 signaling pathway. These findings may also provide new mechanistic insight into the anti-cancer effects of certain compounds in traditional Chinese herbal medicines.
机译:背景小Ber碱是一种源自传统中草药的天然生物碱。调节微RNA(miRNA)的水平是已知的,尽管这种作用的机制尚不清楚。在这里,我们先前证明了在多发性骨髓瘤细胞中,小ber碱对87个miRNA的表达有不同的影响。在49个被下调的miRNA中,有9个起了作用,包括miR-21。整合分析显示,下调的miRNA中有28个参与了肿瘤蛋白p53(TP53)信号传导和其他癌症途径。 miR-21参与所有这些途径,并且是多发性骨髓瘤细胞中受小ber碱影响的最重要的疾病之一。结果我们证实,小ber碱下调了miRNA-21的表达,并显着上调了程序性细胞死亡4(PDCD4)的表达,PDCD4是一种预测的miR-21靶标。萤光素酶报告基因检测证实PDCD4受miR-21直接调控。生物信息学分析表明,miR-21启动子可以被信号转导和转录激活因子3(STAT3)靶向。小ber碱对白介素6(IL6)的下调可能通过多发性骨髓瘤中STAT3的下调来抑制miR-21转录。此外,小ber碱和靶向种子的抗miR-21寡核苷酸均可诱导多发性骨髓瘤细胞株的凋亡,G2期细胞周期阻滞和集落抑制。短干扰RNA耗尽PDCD4可以挽救小ber碱诱导的多发性骨髓瘤细胞的细胞毒性。结论我们的结果表明,小ber碱可能通过IL6 / STAT3下调miR-21水平,至少部分抑制多发性骨髓瘤细胞的生长。这导致PDCD4表达增加,这很可能导致p53信号通路的抑制。这些发现也可能为中药中某些化合物的抗癌作用提供新的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号